Full press release: www.globenewswire.com/news-release...
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
SNIPR Biome today announced the close of a EUR 35 million
Series B financing round addressing antimicrobial resistance and infectious disease....
www.globenewswire.com
August 7, 2025 at 7:17 AM
Full press release: www.globenewswire.com/news-release...
Full press release: www.globenewswire.com/news-release...
SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer....
www.globenewswire.com
June 12, 2025 at 6:52 AM
Full press release: www.globenewswire.com/news-release...
Register here www.microbiomeforum.com/register
Register — Microbiome Times Forum
www.microbiomeforum.com
March 7, 2025 at 10:04 AM
Register here www.microbiomeforum.com/register
Read the full release here: www.globenewswire.com/news-release...
SNIPR Biome Strengthens IP Portfolio with Patent Granted for a Novel CRISPR-Cas System
Grant of a patent on February 26th 2025 by the European Patent Office protecting the newly-discovered and characterised CRISPR-CasS system....
www.globenewswire.com
February 24, 2025 at 10:14 AM
Read the full release here: www.globenewswire.com/news-release...